Apigenin and Quercetin have gained significant attention due to their abundance in fruits and vegetables, as well as their pharmacological properties. These naturally occurring flavonoids are widely researched because of their low toxicity and diverse biological activities.
Apigenin is found in parsley, celery, chamomile, and oranges, whereas Quercetin is abundant in apples, onions, berries, and tea. Both compounds exhibit strong antioxidant properties by scavenging free radicals, reducing oxidative stress, and preventing cellular damage. Their anti-inflammatory effects are mediated through the inhibition of pro-inflammatory cytokines, suppression of NF-κBsignaling pathways, and modulation of immune responses. Furthermore, they have demonstrated significant potential in wound healing by promoting collagen synthesis, enhancing fibroblast proliferation, and improving tissue regeneration.
Additionally, both flavonoids have shown promise as anti-psoriasis agents by modulating keratinocyte proliferation and reducing inflammatory markers. Their anti-cancer activities have been extensively studied, with evidence supporting their role in inhibiting tumor growth, inducing apoptosis, and suppressing metastasis in various cancer models. Moreover, their anti-diabetic properties are attributed to their ability to regulate glucose metabolism, improve insulin sensitivity, and reduce oxidative damage associated with diabetes-related complications.
This review aims to provide comprehensive insights into the pharmacological applications of Apigenin and Quercetin, emphasizing their various properties. By exploring their mechanisms of action and potential therapeutic applications, this research offers a scientific foundation for further studies and the development of novel formulations for medical and pharmaceutical use. Their diverse benefits highlight the need for more in-depth investigations to optimize their clinical applications and enhance their bioavailability.